Business Description
Unity Biotechnology Inc
NAICS : 325411
SIC : 2833
ISIN : US91381U2006
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.57 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.1 | |||||
Debt-to-EBITDA | -0.82 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 48.1 | |||||
3-Year EPS without NRI Growth Rate | 46.5 | |||||
3-Year FCF Growth Rate | 45.5 | |||||
3-Year Book Growth Rate | -52.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 28.37 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.81 | |||||
9-Day RSI | 33.21 | |||||
14-Day RSI | 39.57 | |||||
6-1 Month Momentum % | -7.22 | |||||
12-1 Month Momentum % | -43.66 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.07 | |||||
Quick Ratio | 4.07 | |||||
Cash Ratio | 3.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -46.6 | |||||
Shareholder Yield % | 79.77 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -88.29 | |||||
ROA % | -39.98 | |||||
ROIC % | -119.05 | |||||
3-Year ROIIC % | -127.6 | |||||
ROC (Joel Greenblatt) % | -142.69 | |||||
ROCE % | -46.71 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.19 | |||||
Price-to-Tangible-Book | 1.2 | |||||
EV-to-EBIT | -0.41 | |||||
EV-to-EBITDA | -0.43 | |||||
EV-to-Forward-Revenue | 211.36 | |||||
EV-to-FCF | -0.46 | |||||
Price-to-Net-Current-Asset-Value | 11.35 | |||||
Price-to-Net-Cash | 124.8 | |||||
Earnings Yield (Greenblatt) % | -243.69 | |||||
FCF Yield % | -103.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Unity Biotechnology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -1.622 | ||
Beta | 1.06 | ||
Volatility % | 25.42 | ||
14-Day RSI | 39.57 | ||
14-Day ATR (€) | 0.036496 | ||
20-Day SMA (€) | 1.3454 | ||
12-1 Month Momentum % | -43.66 | ||
52-Week Range (€) | 1.1 - 2.374 | ||
Shares Outstanding (Mil) | 16.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Unity Biotechnology Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Unity Biotechnology Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Unity Biotechnology Inc Frequently Asked Questions
What is Unity Biotechnology Inc(STU:9U90)'s stock price today?
When is next earnings date of Unity Biotechnology Inc(STU:9U90)?
Does Unity Biotechnology Inc(STU:9U90) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |